US Patent Issued to HANMI PHARM. on Feb. 18 for "Crystal form of acid addition salt of furopyrimidine compound" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,510, issued on Feb. 18, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea).

"Crystal form of acid addition salt of furopyrimidine compound" was invented by Hee Sook Oh (Hwaseong-si, South Korea), Jae Hyuk Jung (Hwaseong-si, South Korea), Ji Young Jeon (Hwaseong-si, South Korea), Sun Young Jang (Hwaseong-si, South Korea) and Tae Hee Ha (Hwaseong-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are crystalline forms of acid addition salts of N-(3-(2-(4-(4-methylpiperazin-1-yl)phenylamino)furo[3,2-d]pyrimidin-4-yloxy)phenyl)acrylamide, and a pharmaceutical composition including the same. The crystalline forms may be...